Navitor Pharmaceuticals Investors

16 investors on Angel Roster list Navitor Pharmaceuticals in their portfolio. Most are venture capital firms and corporate venture capital firms, the most common stage is Series B and the largest groups are based in the United States, the United Kingdom and France.

Investors are matched on the company name in their portfolio, so companies that share the name Navitor Pharmaceuticals can appear together.

Investors listed
16
With verified email
63%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 16 Navitor Pharmaceuticals investors

The most complete profiles first. Showing 16 of 16.

  • Jernej GodecVerified

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more

    Verified email available

  • Kevin BittermanVerified

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 70 more

    Verified email available

  • Alan CraneVerified

    Venture Capital · United States

    Health CareWomen FoundedArtificial Intelligence (AI)Information Technology (IT)

    Portfolio: KSQ Therapeutics, Noema Pharma, Quartet Health, Notarize and 82 more

    Verified email available

  • Alex HardingVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more

    Verified email available

  • Jason P. HaflerVerified

    Corporate Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more

    Verified email available

  • Jason RhodesVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more

    Verified email available

  • Laia CrespoVerified

    Venture Capital, Corporate Venture Capital, Investor · France

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more

    Verified email available

  • Marian NakadaVerified

    Venture Capital, Corporate Venture Capital · United States

    Health CareWearablesWellnessWomen Founded

    Portfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more

    Verified email available

  • Matthew FoyVerified

    Corporate Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Semprus BioSciences, Pulmocide, Syntaxin, CRISPR Therapeutics and 50 more

    Verified email available

  • Todd BradyVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: F2G, UNUM Therapeutics, Avidity Biosciences, Avrobio and 10 more

    Contact details available

  • Vijay MurthyVerified

    Venture Capital, Corporate Venture Capital · United States

    Health CareWearablesWellnessWomen Founded

    Portfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more

    Verified email available

  • Asish Xavier

    Venture Capital, Corporate Venture Capital, Investor · United States

    SeedHealth CareWearablesWellnessWomen Founded

    Portfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more

    Contact details available

  • Jeanne Bolger

    Venture Capital, Corporate Venture Capital, Investor · United Kingdom

    Series AHealth CareWearablesWellnessWomen Founded

    Portfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more

    Contact details available

  • Daniel Mansuri

    Corporate Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more

    Contact details available

  • Jean

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more

    Contact details available

  • Steven Robinette

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Navitor Pharmaceuticals investors are on Angel Roster?

Angel Roster lists 16 Navitor Pharmaceuticals investors. 10 of them (63%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (13), Corporate Venture Capital Firms (8) and Private Equity Firms (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Navitor Pharmaceuticals investors invest in?

Among those that list a stage, the most common are Series B (2), Seed (1) and Series A (1).

Where are Navitor Pharmaceuticals investors based?

Most are based in the United States (13), the United Kingdom (2) and France (1).

Which companies have Navitor Pharmaceuticals investors backed?

The most-backed portfolio companies among them are UNUM Therapeutics (10), Padlock Therapeutics (10), Rodin Therapeutics (10), Lysosomal Therapeutics (9) and Cogent Biosciences (9).

How do I contact Navitor Pharmaceuticals investors?

Create a free Angel Roster account to search and filter all 16, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.